Baxter International Inc
NYSE:BAX

Watchlist Manager
Baxter International Inc Logo
Baxter International Inc
NYSE:BAX
Watchlist
Price: 29.3 USD 0.76% Market Closed
Market Cap: 14.9B USD
Have any thoughts about
Baxter International Inc?
Write Note

Gross Margin
Baxter International Inc

38.3%
Current
37%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
38.3%
=
Gross Profit
5.4B
/
Revenue
14B

Gross Margin Across Competitors

Country US
Market Cap 14.9B USD
Gross Margin
38%
Country US
Market Cap 199.9B USD
Gross Margin
56%
Country US
Market Cap 191.9B USD
Gross Margin
67%
Country US
Market Cap 140.8B USD
Gross Margin
64%
Country US
Market Cap 134.7B USD
Gross Margin
69%
Country IE
Market Cap 104.7B USD
Gross Margin
65%
Country US
Market Cap 65.9B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.8B USD
Gross Margin
79%
Country CN
Market Cap 314.4B CNY
Gross Margin
64%
Country US
Market Cap 36.4B USD
Gross Margin
41%
No Stocks Found

Baxter International Inc
Glance View

Market Cap
14.9B USD
Industry
Health Care
Economic Moat
None

Baxter International Inc. finds its roots in the early 1930s, a time when the healthcare landscape was vastly different. Founded by Donald Baxter, a medical doctor seeking to improve the quality and safety of intravenous therapy, the company initially focused on researching and developing safe ways to provide patients with sterile intravenous solutions. As the years unfolded, Baxter transformed itself from a small operation into a globally recognized healthcare giant. Today, it operates in the realm of lifesaving medical products and services, specializing in the development of essential pharmaceuticals, clinical nutrition for hospitals, advanced kidney care solutions, and critical care technology that healthcare providers depend on daily. Central to Baxter's business model is its commitment to innovation and improving patient outcomes, which drives its success and profitability. By leveraging its expertise in areas like renal and hospital products, Baxter is able to cultivate a diversified portfolio. This diversification not only helps the company mitigate risks but also strengthens its market position. Revenue streams are generated through the manufacture and sale of medical devices and pharmaceuticals, catering mostly to hospitals, clinics, and renal care centers worldwide. Baxter consistently reinvests in its research and development, aiming to pioneer novel therapies and products that address the evolving needs of the healthcare sector, ensuring that it remains a key player in the ongoing story of medical progress.

BAX Intrinsic Value
49.15 USD
Undervaluation 40%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
38.3%
=
Gross Profit
5.4B
/
Revenue
14B
What is the Gross Margin of Baxter International Inc?

Based on Baxter International Inc's most recent financial statements, the company has Gross Margin of 38.3%.